Cochrane · systematic review · CD002010

Bisphosphonates for osteoporosis in people with cystic fibrosis

Jeffery, TC, Chang, AB, Conwell, LS · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
18
current version
GRADE rated
10
No studies
3
Included studies
NR
No studies 3 · 16.7%Ungraded 5 · 27.8%Very low 2 · 11.1%Low 7 · 38.9%Moderate 1 · 5.6%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Bisphosphonates compared with control for osteoporosis in people with cystic fibrosis who have not had a lung transplant

Population: adults with cystic fibrosis who have not had a lung transplant
6 questions
OutcomeEffectEvidenceStatus / GRADE
New vertebral fractures
Bisphosphonates vs control
no estimate extracted5 studies · 142 participantsVery low
Downgraded: risk of bias, imprecision
New non‐vertebral fractures
Bisphosphonates vs control
no estimate extracted4 studies · 95 participantsVery low
Downgraded: risk of bias, imprecision
BMD: % change in BMD at the lumbar spine
Bisphosphonates vs control
no estimate extracted6 studies · 171 participantsLow
Downgraded: risk of bias
BMD: % change in BMD at the hip or femur
Bisphosphonates vs control
no estimate extracted5 studies · 155 participantsLow
Downgraded: risk of bias
QoL: change in physical and mental component scores (SF36v2)
Bisphosphonates vs control
no estimate extracted1 study · 47 participantsLow
Downgraded: imprecision, inconsistency
Adverse events: bone pain (all routes of bisphosphonate administration)
Bisphosphonates vs control
no estimate extracted7 studies · 206 participantsModerate
Downgraded: risk of bias

Bisphosphonates compared with placebo for osteoporosis in children with cystic fibrosis who have not had a lung transplant

Population: children with cystic fibrosis who have not had a lung transplant
6 questions
OutcomeEffectEvidenceStatus / GRADE
New vertebral fractures
Bisphosphonates vs placebo
OR 0.32 [0.03, 3.13]1 study · 113 participantsLow
Downgraded: imprecision
New non‐vertebral fractures
Bisphosphonates vs placebo
OR 0.19 [0.01, 4.04]1 study · 113 participantsLow
Downgraded: imprecision
BMD: % change in BMD at the lumbar spine
Bisphosphonates vs placebo
no estimate extracted1 study · 113 participantsLow
Downgraded: imprecision
BMD: % change in BMD at the hip or femur
Bisphosphonates vs placebo
no estimate extractedNRNo studies
QoL
Bisphosphonates vs placebo
no estimate extractedNRNo studies
Adverse events
Bisphosphonates vs placebo
no estimate extracted1 study · 113 participantsLow
Downgraded: imprecision

Bisphosphonates compared with no bisphosphonates for osteoporosis in people with cystic fibrosis who have had a lung transplant

Population: adults with cystic fibrosis who have had a lung transplant
6 questions
OutcomeEffectEvidenceStatus / GRADE
New vertebral fractures
Bisphosphonates vs no bisphosphonates
no estimate extracted12 participantsUngraded
New non‐vertebral fractures
Bisphosphonates vs no bisphosphonates
no estimate extracted12 participantsUngraded
BMD: % change in BMD at the lumbar spine
Bisphosphonates vs no bisphosphonates
no estimate extracted12 participantsUngraded
BMD: % change in BMD at the hip or femur
Bisphosphonates vs no bisphosphonates
no estimate extracted12 participantsUngraded
QoL
Bisphosphonates vs no bisphosphonates
no estimate extractedNRNo studies
Adverse events
Bisphosphonates vs no bisphosphonates
no estimate extracted12 participantsUngraded